COVID-19 Research: Navigating the European General Data Protection Regulation
Becker R, Thorogood A, Ordish J. Journal of Medical Internet Research Vol 22. No 8 (2020). 27 August 2020
Babb de Villiers C, Kroese M, Moorthie S. Journal of Medical Genetics Online First. 6 May 2020.
Congenital disorders: epidemiological methods for answering calls for action
Modell B, Darlison M.W, Malherbe H, Moorthie S, Blencowe H, Mahaini R, El-Adawy M.
Journal of Community Genetics. 2018, Vol 9 issue 4, pp 335-340.
Moorthie S, Blencowe H, Darlison M.W, Lawn J.E, Mastroiacovo P, Morris J.K, Modell B, Congenital Disorders Expert Group.
Journal of Community Genetics. 2018; Volume 9, Issue 4, pp347-362.
Blencowe H, Moorthie S, Darlison M.W, Gibbons S, Modell B, Congenital Disorders Expert Group.
Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 363-376.
Chromosomal disorders: estimating baseline birth prevalence and pregnancy outcomes worldwide
Moorthie S, Blencowe, H, Darlison M.W, Gibbons S, Lawn J.E, Mastroiacovo P, Morris J.K, Modell B, Congenital Disorders Expert Group.
Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 377-386.
Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide
Moorthie S, Blencowe H, Darlison, M.W, Lawn J, Morris J.K, Modell, B, Congenital Disorders Expert Group.
Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 387-396.
Genetic database software as medical devices
Thorogood A, Touré S.B, Ordish J, Hall A, Knoppers B.
Human Mutation. 2018; Vol. 39 Iss.11. pp1702-1712.
AI for health: Is there a regulatory gap?
Digital Health Legal. June 2018; Volume: 5 Issue: 6.
Rare single gene disorders: estimating baseline prevalence and outcomes worldwide
Blencowe H, Moorthie S, Petrou M, Hamamy H, Povey S, Bittles A, Gibbons S, Darlison M, Modell B, Congenital Disorders Expert Group
Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 397-406.
Samuel, G, Howard H.C, Cornel M, van El C, Hall A, Forzano F, Prainsack B.
Forensic Science International. 2018 5 July; Genetics (online).
Risk stratification, genomic data and the law
Hall A, Finnegan T, Susmita C et al.
J Community Genet. 2018;9:195.
Murtagh M, B Mwenza, H Alison et al.
Hum Genomics. 2018;12:24
Risk stratification, genomic data and the law.
Hall A, Finnegan T, Chowdhury S, Dent T, Kroese M, Burton H.
J Community Genet. 2018; https://doi.org/10.1007/s12687-018-0358-4. [Epub ahead of print]
Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis
Belncowe H, Kancherla V, Moorthie S, et al.
Annals of the New York Academy of Sciences. 2018 Jan 24; doi:10.1111/nyas.13548. [Epub ahead of print]
Moorthie S, Blencowe H, W Darlison M, et al Congenital Disorders Expert Group.
J Community Genet. 2017 Oct 11; doi: 10.1007/s12687-017-0335-3. [Epub ahead of print]
Chromosomal disorders: estimating baseline birth prevalence and pregnancy outcomes worldwide.
Moorthie S, Blencowe H, Darlison MW, et al, Congenital Disorders Expert Group.
J Community Genet. 2017 Sep 26; doi: 10.1007/s12687-017-0336-2. [Epub ahead of print]
Genomic medicine and data sharing
Raza S, Hall A.
Br Med Bull. 2017 Sep; 1;123(1):35-45.
Exploring the potential duty of care in clinical genomics under UK law
Mitchell C, Ploem C, Chico V, Ormondroyd E, Hall A, Wallace S, Fay M, Goodwin D, Bell J, Phillips S, Taylor J.C, Hennekam R, Kaye J.
Medical Law International. 2017 Aug 14 [Epub ahead of print]
Lacerda, EM. Nacul, L. Pheby, D. Shepherd, C. Spencer, P. Exploring the feasibility of establishing a disease-specific post-mortem tissue bank in the UK: a case study in ME/CFS Journal of Clinical Pathology. 2010; doi:10.1136/jcp.2010.082032
Crawford G, Fenwick A, Foulds N, Hallowell N, Lucassen A. Genetic medicine and incidental findings: it is more complicated than deciding whether to disclose or not Journal of Medical Genetics. 2013 Nov;15(11):896-9
Griffiths S, Hallowell N, Yeung Leung T, Yi H. Motivations for Undertaking a DNA Sequencing-Based Non-Invasive Prenatal Testing for Fetal Aneuploidy: Qualitative Study with Early Adopter Patients in Hong Kong PLOS One. 2013 Nov 27
Big data or bust - realising the microbial genomics revolution
Microbial Genomics. 18 December 2015; 10.1099/mgen.0.000046
Alberg C, Nacul L, Pashayan N, Shannon G.
Matern Child Health J. 2013 Nov 14.
Alberg C, Nacul L, Pashayan N, Shannon G.
Matern Child Health J. 2013 Oct 4.
Chowdhury S, Hall A, Pashayan N, Pharoah P.
Journal of Medical Ethics. 2013 Mar 1 [Epub ahead of print] PubMed PMID: 23454719
Bewshea C, Carrieri D, Hall A, Walker G.
J Med Ethics doi:10.1136/medethics-2016-103530
Chitty LS, Wright D, Kroese M. et al
BMJ. 2016 Jul 4;354:i3426.
Responsible implementation of expanded carrier screening
Henneman L, Borry P, Hall A.
Eur J Hum Genet. 2016 Jun; 24(6)w1-e12.
Kadir A, Mossey PA, Blencowe H, Moorthie S et al.
Cleft Palate Caniofac J. 2016 Jul 19 [Epub ahead of print]
Muka T, Oliver-Williams C, Chowdhury S et al.
PloS One. 2016 Jun 17; 11(6):e0157417.
Known unknowns: building an ethics of uncertainty into genomic medicine
Gaff C, Hall A, Leonard S, Newson A.
BMC Medical Genomics (2016) 9:57 DOI 10.1186/s12920-016-0219-0
Warren-Gash C, Kroese M, Burton H, Pharoah P.
Hered Cancer Clin Pract. 2016 Jun; 1;14:12.
Preparing clinicians for genomic medicine
Burton H, Slade I.
Postgrad Med J. 2016 Jul;92(1089):369-71. doi: 10.1136/postgradmedj-2016-133962. Epub 2016 Mar 21.
Pathogen genomics into practice: from promising research to real health impact
Moorthie S, Luheshi L.
Microbiology Today. 2016 February; 43:1.
Moving pathogen genomics out of the lab and into the clinic: what will it take?
Genome Medicine. 30 December 2015; DOI: 10.1186/s13073-015-0254-z
Realising the promise of non-invasive prenatal testing
Chitty LS, Kroese M.
BMJ. 2015 Apr 10;350:1792.
Cost Effectiveness of Using Array-CGH for Diagnosing Learning Disability
Sagoo GS, Mohammed S, Barton G, Kroese M et al.
Applied Health Economics and Health Policy. 2015; 13,4, 421-432.
de Wert G, Dondorp W, Hall A.
European Journal of Human Genetics. 2015 March 18.
Bowman E, Goldring K, Gveric D, Hall A, Lacerda E, Nacul L, O'Donovan D, Pheby D.
BMC Research Notes. 2014; (7):370.
Personalized medicine: what's in a name?
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G, Stewart A.
Personalised Medicine. 2014; 11(2):197-210.
Moorthie S, Cameron L, Sagoo G, Bonham J, Burton H.
Journal of Inherited Metabolic Disease. 2014 Nov; 37(6):889-898.
The impact of genetics on public health practice
Abubakar I, Burton H, Jackson C.
British Medical Bulletin. 2014 Oct; 112(1):37-46.
Borry P, Cornel M, Kroese M, Severin F.
European Journal of Human Genetics. 2014 Sept 24.
Beyond public health genomics: proposals from an international working group
Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Knoppers BM, Khoury MJ, Meslin EM, Van Dijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W.
Eur J Public Health. 2014 Dec; 24(6):877-9.
Alberg C, Hall A, Hallowell N, Zimmern R.
Journal of Medical Ethics. Epub 2014 Jul 18.
Boustred C, Chitty L, Daley R, Fisher J, Hill M, Howarth A, Kroese M, Lench N, Lewis C, Lo K, Mason S, Mckay F, Morris S, Plagnol V, Spencer K, wright D.
BMC Pregnancy Childbirth. 2014 Jul 16; 14:229.
From the lab to the maternity ward: how genetics can beat birth defects
The Guardian. 2014 July 9.
Nacul L,Stewart A, Alberg C, Chowdhury S, Burton H, Darlison MW, Grollman C, Hall A, Modell B, Moorthie S, Sagoo G, .
Journal of Public Health. 2014 June; 36(2):243-50. doi: 10.1093/pubmed/fdt048 : May 10, 2013 [Epub ahead of print]
Bahl R, Lawn J, Wall S. Newborn health research priorities beyond 2015 The Lancet. 2014 July 12;384(9938):e27-e29.
Alberg C, Nacul L, Pashayan N, Shannon G.
Maternal and Child Health Journal. 2014 August; 18(6):1354-79.
Personalised medicine in the UK: challenges of implementation and impact on healthcare system
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G.
Genome Medicine. 2014 Apr 25; 6(4):28.
Burton H, Chowdhury S, Hall A, Pashayan N, Pharoah P.
Journal of Medical Ethics. 2014 Mar; 40(3):163-7.
Issues concerning the evaluation and regulation of predictive genetic testing
J Community Genet. 2014 Jan; 5(1):49-57.
Familial Hypercholesterolaemia: a pressing issue for European health care
Aitman T, Brice P, Burton H, Edwards C, Humphries S.
Atherosclerosis. 2013 December; 231(2): 223-226
Recommendations for returning genomic incidental findings? We need to talk!
Bennett R, Botkin J, Burke W, Clayton E, Henderson G, Holm I, Jarvik G, Khoury M, Knoppers B, Matheny A, Press N, Ross L, Rothstein M, Saal H, Uhlmann W, Wilfond B, Wolf S, Zimmern R.
Genet Medicine. 2013 Nov; 15(11):854-9.
Public health genomics and personalised prevention: lessons from the COGS project
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Internal Medicine. 2013 Nov; 274(5):451-6
Policy challenges of clinical genome sequencing
Birney E, Burton H, Cunningham F, Firth H, Hurst J, Middleton A, Wright C.
British Medical Journal. 2013 Nov 22; 347:f6845.
Life insurance: genomic stratification and risk classification
Burton H, Chowdhury S, Dent T, Feze I, Foulkes W, Hall A, Hamet P, Joly Y, Kirwan N, Knoppers B, Macdonald A, Pashayan N, Simard J, Van Hoyweghen I.
European Journal of Human Genetics. 2013 Oct 16. doi: 10.1038/ejhg.2013.228
Schuler-Faccini L, Sanseverino M, de Rocha Azevedo L, Moorthie S, Alberg C, Burton H, Chowdhury S, Sagoo G, Burton H, Nacul L.
J Community Genet. 2013 Aug 30. [Epub ahead of print]
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Public Health (Oxf). 2013 Aug 28.
Systematic review of birth prevalence of neural tube defects in India
Bhide P, Sagoo G, Moorthie S.
Birth Defects Res A Clin Mol Teratol. 2013 Jul; 97(7):437-43.
Christianson A, Zimmern R.
J Community Genet. 2013 Jun 23 [Epub ahead of print] PMID: 23794314
Finnegan, Tom. Harvey, Kate. Jagadesham, Varsha. Joynson, Catherine. Mills, Peter. Perkins, Carol. Riley, Laura. Svenning Berg, Ranveig. Walker-Robson, Sarah. White, Johanna. Whittall, Hugh. Wright, Katharine.. Review of the Nuffield Council on Bioethics Report: Novel Techniques for the prevention of mitochondrial DNA disorders: an ethical review Genomics, Society and Policy 8:29-31 (2013)
Alberg C, Nacul L, Pashayan N, Shannon G.
BJOG. 2013 Apr; 120(5):555-66. doi: 10.1111/1471-0528.12116. Epub 2013 Jan 18.
Alsop K, Bowtell D, Crook A, Gleeson M, Hallowell N, Mitchell G, Plunkett L. The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study Genetics in Medicine. 2013; 15:458-465
Public health implications from COGS and potential for risk stratification and screening
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Nature Genetics. 2013 Apr; 45(4):349-51 doi: 10.1038/ng.2582. PubMed PMID: 23535723
Informatics and clinical genome sequencing: opening the black box
Moorthie S, Hall A, Wright C.
Genet Medicine. 2013 Mar; 15(3):165-71.
Incorporating genomics into breast and prostate cancer screening: assessing the implications
Burton H, Chowdhury S, Dent T, Hall A, Hall P, Lyratzopoulos G, Pashayan N, Pharoah P.
Genetics in Medicine. 2013 Feb 14 doi: 10.1038/gim.2012.167. [Epub ahead of print] PubMed PMID: 23412607.
The use of a toolkit for health needs assessment on neural tube defects in Argentina
Groisman B, Liascovich R, Barbero P, Alberg C, Moorthie S, Nacul L, Sagoo G.
J Community Genet. 2013 Jan; 4(1):77-86.
Stratified cancer screening: the practicalities of implementation.
Burton H, Chowdhury S, Dent T, Eccles D, Eeles R, Hall A, Jbilou J, Lyratzopoulos G, Pashayan N, Pharoah P, Rafi I, Segnan N, T.
Public Health Genomics. 2013;16(3):94-9.
Next-generation sequencing in the clinic: are we ready?
Biesecker L, Burke W, Kohane I, Plon S, Zimmern R.
Nat Rev Genet. 2012 Nov; 13(11):818-24. doi: 10.1038/nrg3357
Higgins J, Sagoo G, Wei Y, Wright C.
BMC Res Notes. 2012 Sep; 1;5:476.
The impact of genomics on public health practice: the case for change
Khoury M, Zimmern R.
Public Health Genomics. 2012; 15(3-4):118-24.
Bellingan L, Bellingham J, Sutherland W. A collaboratively-derived science-policy research agenda PLoS One. 2012;7(3):e31824
Brayne C, Dent T, Janssens A, Stephan B, Wright C. Risk Prediction Models: a framework for assessment Public Health Genomics. 2012; 15(2):98-105
Zenner D. Predictive power of Koplik's spots for the diagnosis of measles Journal of Infection in Developing Countries. 2, 2012; 6(3):271-275
The impact of whole genome sequencing on the NHS and population health
British Society for Human Genetics. Jan 2012; Newsletter No 46.
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine1
Burton H, Dove E, Fisher E, Masellis M, Ozdemir V, Warnich L, Wright C.
Current Pharmacogenomics and Personalized Medicine. 2012 Jan 1; 10(1);1-6.
Genomics and individuals in public health practice: are we luddites or can we meet the challenge?
Journal of Public Health (Oxf). 2011 Dec; 33(4):477-82.
Review of Massively Parallel DNA sequencing technologies
Mattocks C, Moorthie S, Wright C.
The HUGO Journal. 2011.
Alberg C, Behr E, Burton H, Raju H, Sagoo G.
British Medical Journal. 2011 Nov 21; 343:d6966. doi: 10.1136/bmj.d6966
Personalised Medicine: Lessons from Birth Defects and Single Gene Disorders
Burton H, Sanderson S.
Current Pharmacogenetics & Personalised Medicine. 2011; 9(2): 80-83.
Dent T, Greenhalgh T, Mathur R, Meads C, Noble D. Risk models and scores for type 2 diabetes: systematic review British Medical Journal. 2011;343:d7163
Dent T. Educating about risk scores in primary care Education for Primary Care. 2011; 22: 291-292
Pashayan N, Pharoah P. Translating genomics into improved population screening - hype or hope? Human Genetics. 2011; doi:10.1007/s00439-011-0985-x
Campion P, Drachler M, Fayyaz S, Howe A, Leite J, Molokhia M, Poland F. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care BMC Medicine. 2011, 9:91 (28 July 2011)
Campion Peter, Curran Monica, de Carvalho Leite, José Carlos, de Lourdes Drachler Maria, Fayyaz Shagufta, Featherstone Valerie, Howe Amanda, Lacerda Eliana, Nacul Lius, Pheby Derek, Poland Fiona, Sakellariou Dikaios. A Disease Register for ME/CFS : Report of a Pilot Study BMC Research Notes. 2011, 4:139 doi:10.1186/1756-0500-4-139
Campion P, Drachler M, Fayyaz S, Howe A, Leite J, Molokhia M, Poland F. The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers BMC Public Health. 2011, 11:402doi:10.1186/1471-2458-11-402
Cork M, Sagoo G, Tazi-Ahnini R, Vasilopoulos Y, Walters K.
Journal of Human Genetics. 2011 Mar; 17.
Burney P, Jarvis D, Minelli C, Sagoo G, Shaheen S, Wei I.
American Journal of Epidemiology. vol 173 Iss 6 pp 603-620.
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
Burton H, Chowdhury S, Dent T, Duffy S, Easton D, Eeles R, Neal D, Pashayan N, Pharoah P.
British Journal of Cancer. Advance online publication, 2011 April 5; doi:101038/bjc2011.118
Legal and ethical implications of inherited cardiac disease in clinical practice within the UK
Journal of Medical Ethics. 2010; 36: 762-766.
A framework for the prioritization of investment in the provision of genetic tests
Alberg C, Burton H, Kroese M, Lakshman R, Whittaker J.
Public Health Genomics. 2010; 13 (7-8) 538-43.
Tay Sachs disease carrier testing in the UK Jewish population
British Journal of Midwifery. 2010; 18(4):220-224.
Burke W, Hall A, Karmali M, Khoury M, Knoppers B, Meslin E, Stanley F, Wright C, Zimmern R.
Genetics in Medicine. 2010 Nov; Vol 15.
Regulating direct-to-consumer genetic tests: What is all the fuss about?
Genetics in Medicine. 2010 Oct 1 [Epub ahead of print]
Realising the benefits of genetics for health
Brice P, Burton H, Stewart A, Wright C.
The Lancet. 2010 Oct; 23;376(9750):1370-1.
Hitchcock J, Polak J, Prescott C. Chapter on the European stem cell patent landscape on commercialising regenerative medicine in "The delivery of regenerative medicines and their impact on healthcare" CRC Press. November 2010
Gregory-Jones S, Wright C. Size of the direct-to-consumer genomic testing market Genetics in Medicine. 2010 Sep;12(9):594
Horton, Simon. Poland, Fiona. Kale, Swati. de Lourdes Drachler, Maria. de Carvalho Leite, Jose Carlos. McArthur, Maggie A. Campion, Peter D. Pheby, Derek. Nacul, Luis. Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME) in adults: a qualitative study of perspectives from professional practice BMC Family Practice. 2010, 11:89
Dent T. Predicting the risk of coronary heart disease I: The use of conventional risk markers Atherosclerosis. 2010; 213: 345-351
Atherosclerosis. 2010; 213: 352-362.
Flowers J, Soljak M. COPD in England: a comparison of model-based prevalence and observed prevalence from general practice data Journal of Public Health. 2010, doi 10.1093/pubmed/fdq031
Burton H, Stewart A. Mainstreaming genetics: a comparative review of clinical services for inherited cardiovascular conditions in the UK. Public Health Genomics. 2010;13(4):235-45. Epub 2010 Apr 15
Campbell H, Gyllensten U, Janssens A, Mascalzoni D, McQuillan R, Pramstaller P, Rudan I, Stewart A, van Duijn C, Wilson J. Comparison of participant information and informed consent forms of five European studies in genetic isolated populations European Journal of Human Genetics.
Bennett C, Burke S, Burton H, Farndon P.
BMC Health Services Research. 2010 May; 14;10:125.
Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications
Bostanci A, Hall A, Wright C.
Public Health Genomics. 2010; 13(4):246-55. Epub 2010 Apr 15.
Genomics and public health: translating research into public benefit
OLeary P, Zimmern R.
Public Health Genomics. 2010; 13(4):193-6. Epub 2010 Apr 15.
Inherited cardiovascular conditions: the challenges of genomic medicine
Alberg C, Burton H, Hall A, Inherited Cardiovascular Conditions Services , Sagoo G, Stewart A.
Heart. 2010 Mar; 96(6):474-6
Burton H, Ells L, Flowers J, Pencheon D, Wilkinson J.
Public Health Genomics. 2010 Mar 29; [Epub ahead of print].
Addressing congenital causes of disability
Nacul L, Moorthie S, Kapila M, Zimmern R.
The Lancet. 2010 Jan 30; 375(9712):374.
Developing stakeholder involvement for introducing public health genomics into public policy
Adams M, Bunton R, Burton H, Schroeder-Baeck P.
Public Health Genomics. 2009; 12:11-19.
Adams M, Burton H.
Public Health Genomics. 2009; 12(4):216-24.
Biomarkers, Dementia, and Public Health
Brayne C, Hall A, Matthews F, Wright C.
Annals of the New York Academy of Sciences. 2009; 118:11-19.
Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?
Kroese M, Wright C.
Human Genetics. 2009; doi:10.1007/s00439-009-0767-x
Hong Kong Medical Journal. 2009 Oct;15(5):324-5.
A new strategic phase for genomic medicine in UK health services
Burton H, Wright C, Zimmern R.
Genome Medicine. 2009 Oct; 12;1(10):93
Genetics in ophthalmology: equity in service provision?
Journal of Public Health. 2009; doi: 10.1093/pubmed/fdp110
Wright C. Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing British Medical Journal. 2009; 339: 161-164
Burton H, Butterworth A, Higgins J, Sagoo G, Sanderson S, Shaw-Smith C.
Genetics in Medicine. 2009 Mar; 11(3): 139-46
Systematic reviews of genetic association studies
Higgins J, Little J, Sagoo G.
PLoS Medicine. 2009 Mar; 3;6(3):e28.
Testing challenges: evaluation of novel diagnostics and molecular biomarkers
Clinical Medicine. 2009 Feb; 9(1): 68-73.
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis
Burton H, Wright C.
Human Reproduction Update. 2008 Oct 22 [Epub ahead of print].
Genetic tests for common diseases: new insights, old concerns
Hogarth S, Liddell K, Ling T, Melzer D, Sanderson S, Zimmern R.
British Medical Journal. 2008 Mar; 15;336(7644):590-3
How can genetic tests be evaluated for clinical use? Experience of the UK Genetic Testing Network.
Kroese M, Zimmern R, Farndon P, Stewart F, Whittaker J.
Eur J Hum Genet. 2007;15:917-21.
Will genomics widen or help heal the schism between medicine and public health?
Bowen S, Burke W, Gwinn M, Khoury M, Zimmern R.
American Journal of Preventive Medicine. 2007 Oct; 33(4):310-17
Defining purpose: a key step in genetic test evaluation
Genetics in Medicine. 2007; 9(10):675-681
HER2 status in breast cancer - an example of pharmacogenetic testing
Kroese M, Pinder S, Zimmern R.
Journal of the Royal Society of Medicine. 2007 Jul; 100(7):326-9
Bennett C, Burton H, Farndon P.
Familial Cancer. 2007; 6(2):171-80
The evaluation of genetic tests
Journal of Public Health. 2007 May 24; [Epub ahead of print]
A roadmap for developing an efficient and reliable human genome epidemiology
Gwinn M, Higgins J, Ioannidis J, Little J, Zimmern R.
Nature Genetics. 2006; 38(1):3-5
The frequency of inherited metabolic disorders in the West Midlands, United Kingdom
Burton H, Green A, Preece M, Sanderson S.
Archives of Disease in Childhood. 2006.
Burton H, Lee P, Sanderson S, Shortland G.
Journal of Inherited Metabolic Disease. 2006.
Brice P, Burton H, Higgins J, Sagoo G, Sanderson S, Subramonia-Iyer S.
Genetics In Medicine. 2006
Bellagio Group , Burke W, Khoury M, Stewart A, Zimmern R.
Genetics In Medicine. 2006 Jul; 8(7):451-8
Sanderson S.
American Journal of Epidemiology. 2006.
Public health genomics: origins and basic concepts
Stewart A, Zimmern R.
Italian Journal of Public Health. 2006; 3, 9-15.
Knowledge sharing and 'genomic' healthcare
Brice P, Dutta I, Wallace S.
Nature Biotechnology. 2005; 23(2):169-70
Medical Education. 2005; 39(3):243-4
Pharmacogenetics: policy needs for personal prescribing
Detmer D, Ling T, Melzer D, Raven A, Zimmern R.
Journal of Health Services Research and Policy. 2005; 10(1):40-4
Emery J, Higgins J, Kroese M, Patch C, Sanderson S, Zimmern R.
Genetics in Medicine. 2005; 7(7):495-500
Corrigan O. Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report Journal of Medical Ethics. 2005;31(3):144-8
Liddell K, Wallace S. Emerging Regulatory Issues for Human Stem Cell Medicine Genomics, Society and Policy. 2005;1(1):54-73
Emery J, Higgins J, Sanderson S. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: A HuGEnet trade mark systematic review and meta-analysis Genetics In Medicine. 2005;7(2):97-104
Beyond Bristol and Alder Hey: The Future Regulation of Human Tissue
Hall A, Liddell K.
Medical Law Review. 2005; Summer:170-223
Genetic tests and their evaluation: Can we answer the key questions?
Genetics in Medicine. 2004; 6(6):475-80
The Human Tissue Bill and the Mental Capacity Bill
Liddell K, Menon D, Zimmern R.
British Medical Journal. 2004; 328(7455):1510-1
Corrigan O, Tutton R. Genetic Databases: Social-ethical issues in the collection and use of DNA 2004
Ensuring the appropriate use of genetic tests
Burke W, Zimmern R.
Nature Reviews Genetics. 2004; 5(12):955-8
Postregistration genetics education provision for nurses, midwives and health visitors
Burton H, Metcalfe A.
Journal of Advanced Nursing. 2003; 44(4):350-9
The NHS in the era of genetics: implications for community practitioners
Community Practitioner. 2003;76(8):288-90
Genetics education for nurses, midwives and health visitors
Burton H, Metcalfe A, Shuttleworth A.
Professional Nurse. 2003; 18(12):676-80
Health Service Journal. 2003; 113(5868):29
Genetics education for pharmacists
Burton H, Shuttleworth A.
The Pharmaceutical Journal 2003; 270(7232):84-5
(Almost) three cheers for UK genetics White Paper
Stewart A, Zimmern R.
The Lancet. 2003; 362(9381):341-2
Corrigan O, Williams-Jones B. The bioethical problem of DNA investment banking Studies in History and Philosophy of Biological and Biomedical Science. 2003;In press
Corrigan O. Empty ethics: the problem with informed consent Sociology of Health & Illness. 2003;25(3):768-92
Liddell K. Purposive interpretation and the march of genetic technology. Case comment on the R v HFEA 2 W.L.R. (cell nuclear transfer case) Cambridge Law Journal. 2003;62(3):563-6
Gametes, money, and egg sharing
Hope T, McMillan J.
The Lancet. 2003; 362(9383):584
Rhetoric and hype: Where's the "ethics" in pharmacogenomics?
Corrigan O, Williams-Jones B.
American Journal of Pharmacogenomics. 2003;3(6):375-83
Genetics education for midwives
Burton H, Shuttleworth A.
Royal College of Midwives. 2003; 6(4):162-4
From Mendel to the Human Genome Project: the implications for nurse education
Burton H, Stewart A.
Nurse Education Today. 2003; 23(5):380-5
Regulatory options for pharmacogenetics
Detmer D, Ling T, Melzer D, Zimmern R.
Pharmacogenomics. 2003; 4(5):527-30
Pharmacogenetics and public policy: expert views in Europe and North America
Detmer D, Melzer D, Zimmern R.
Pharmacogenomics. 2003; 4(6):689-91
Genetics education for primary health care nurses
Burton H, Shuttleworth A.
Primary Health Care. 2003; 13(4):35-8
Melzer D, Zimmern R.
British Medical Journal. 2002;324(7342):863-4
Science and society: Genetics education for primary-care providers
Burke W, Emery J.
Nature Reviews Genetics. 2002;3(7):561-6
Austin M, Zimmern R.
Genetics in Medicine. 2002;4(4):275-8
Polygenic susceptibility to breast cancer and implications for prevention
Antoniou A, Bobrow M, Easton D, Pharoah P, Ponder B, Zimmern R.
Nature. 2002;31(1):33-6
Olinton M, Pattusi M, Prediger C, Ziegler D. Effects of soy proteina containing isoflavones on women's lipido profile: a meta-analylsis Revista de Nutri
Morgan M, Wallace S. The international human genome project: an overview